Buyouts staff
Inside: How innovation is driving deals in healthcare; Healthcare investors are waking up to social inequality; And expert comment from The Vistria Group in this special report
Inside: The LP brain drain – how overworked investors are moving on; LPs and GPs butt heads over fees; Blackstone on the opportunities its Tac Opps team is finding in a dislocated climate; Plus much more…
Inside: Sweet deals – Why LPs are getting a taste for co-investing; A LP’s tale of co-investing; Expert comment and analysis from Neuberger Berman, Manulife Investment Management and Adams Street; Plus much more…
Inside: Food, glorious food – private equity’s new investment craving; Why Beatrice Mitchell sees dealflow on the rise; How GPs are targeting the life sciences sector; Plus much more…
Inside: The Buyouts 100 list of North America’s biggest fundraisers; Apollo and Clairvest count their casino chips; Why GPs are from Mars and LPs are from Venus; Advent managing partner John Maldonado on his firm’s secret sauce; Plus much more…
How we compiled our ranking of North America's top fund managers.
Emerging managers can provide an edge in pursuing niche, overlooked or special strategies, say Adams Street’s Sunil Mishra, Sergey Sheshuryak and James Korczak.
Inside: How emerging managers are using complex gambits in a tough market; Ten emerging managers to watch; The rise of sector specialists; Crestview’s Hollywood deal with Gersh; Plus much more…
Inside: To sell or not to sell – How LPs are dealing with a delicate balancing act; Key questions facing the secondaries sector; The rise of NAV lending; Expert comment and analysis from industry leaders; Plus much more…
Inside: Apollo’s David Sambur and Matt Nord on being bullish about volatility; LPs raise questions about valuations… and how technology is helping GPs answer those questions; Why impact investors can’t ignore emerging markets; Plus much more…